Cure Alzheimer's Fund Cure Alzheimer's Fund

Longitudinal Study of AD Genotypes

2006

This study draws on a unique community-based longitudinal cohort of 378 subjects who span the range of impairment between normal aging and mild Alzheimer’s disease (AD). This research focuses on two key steps to find AD genes and to understand their impact.

  1. Investigate the relationship of amyloid deposition to memory impairment using Pittsburgh Compound B (PIB), a new imaging technique.
  2. Collect DNA samples for a complete a genome screen of the full cohort, and analyze using a set of optimal quantitative phenotypes. The hypothesis is that longitudinal quantitative phenotypes will provide greater power to detect AD genes than conventional affection status (AD vs. no AD) approaches.

Deborah Blacker Foundational Genetic Risk Factors

Funding to Date

$100,000

Focus

Foundational, Genetic Risk Factors

Researchers

Deborah Blacker, M.D., Sc.D.

Related Content:


Systematic Assessment of Tandem Repeats in Alzheimer’s Disease (STaR-AD) Lars Bertram Valerija Dobricic 2024-02-28 Interpreting Alzheimer’s Disease-Associated Genetic Variation at Enhancer Regions Andreas R. Pfenning 2024-02-01 Moving the Cure Alzheimer’s Fund Genome Project Beyond Simple Associations: Integrating Functional Information, Fine-Mapping and Causal Inference Approaches into the Family-Based Analysis of the Cure Alzheimer’s Fund Whole-Genome Sequencing (WGS) Family Study Christoph Lange 2024-02-01 Characterization and Validation of Two Recently Created Sheep Models of Alzheimer’s Disease in Preparation for Use as a Preclinical Pharmaceutical Testing Model Russell G. Snell Natasha McKean 2024-01-31 Utility of Blood-Based Markers for Predicting Amyloid-Related Imaging Abnormalities and Their Course in Mild Cognitive Impairment and Alzheimer’s Disease Subjects Undergoing Routine Clinical Treatment with Amyloid-Directed Antibodies P. Murali Doraiswamy 2024-01-12 Growth, Characterization and Distribution of a Neurodegenerative Disease-Focused Fibroblast/iPS Cell Bank to Support Molecular Models of Patient-Specific Variation with Validation in Matched Donated Brain Tissues Derek H. Oakley 2023-12-08 Multidisciplinary Phenotyping of a Novel Humanized LOAD Mouse Model Giuseppina Tesco 2023-10-25 Dissecting Alzheimer’s Disease Phenotypes in Directly Reprogrammed Patient-Derived Neurons Andrew S. Yoo 2023-10-25